Show simple item record

dc.contributor.authorMullarkey, C
dc.contributor.authorCrowley, E
dc.contributor.authorMartin, C
dc.date.accessioned2013-10-17T15:59:23Z
dc.date.available2013-10-17T15:59:23Z
dc.date.issued2013-10
dc.identifier.urihttp://hdl.handle.net/10147/303572
dc.description.abstractThis study describes the introduction of Ondansetron to an established waiting room Oral Rehydration Therapy (ORT) for Emergency Department (ED) children with acute gastroenteritis, and evaluates its impact on intravenous fluid administration and admissions. Children who failed initial ORT while waiting further medical assessment received Ondansetron and ORT reattempted. Data collected over a six week period in 2009 was compared to a similar period in 2008 when children received ORT without an anti-emetic. Outcome measures included intravenous fluid administration, admission. Rates of IVF administration reduced by 19% [88/215 (40.9%) in 2008, 51/234 (21.7%) in 2009, p < 0.0001] with a 1.6% reduction in admission rates [31/215 (14.41%) vs 30/234(12.82%) p=0.62]. Thirty four patients received Ondansetron, 79% were successfully rehydrated orally. The addition of Ondansetron to our established ORT programme has successfully reduced rates of IVF administration and admissions in children with gastroenteritis.
dc.language.isoenen
dc.publisherIrish Medical Journal (IMJ)en_GB
dc.subjectCHILD HEALTHen_GB
dc.subject.otherGASTROINTESTINAL DISORDERSen_GB
dc.subject.otherDRUG THERAPYen_GB
dc.titleThe addition of ondansetron to a oral rehydration protocol for children with acute gastroenteritisen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journal (IMJ)en_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-23T08:48:47Z
html.description.abstractThis study describes the introduction of Ondansetron to an established waiting room Oral Rehydration Therapy (ORT) for Emergency Department (ED) children with acute gastroenteritis, and evaluates its impact on intravenous fluid administration and admissions. Children who failed initial ORT while waiting further medical assessment received Ondansetron and ORT reattempted. Data collected over a six week period in 2009 was compared to a similar period in 2008 when children received ORT without an anti-emetic. Outcome measures included intravenous fluid administration, admission. Rates of IVF administration reduced by 19% [88/215 (40.9%) in 2008, 51/234 (21.7%) in 2009, p < 0.0001] with a 1.6% reduction in admission rates [31/215 (14.41%) vs 30/234(12.82%) p=0.62]. Thirty four patients received Ondansetron, 79% were successfully rehydrated orally. The addition of Ondansetron to our established ORT programme has successfully reduced rates of IVF administration and admissions in children with gastroenteritis.


Files in this item

Thumbnail
Name:
Article7098.pdf
Size:
21.13Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record